fluorouracil has been researched along with sphingosine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Gupta, M; Gupta, S; Mahajan, A; Tiwary, AK | 1 |
| Alexander, H; Alexander, S; Min, J; Stegner, AL | 1 |
| Alexander, H; Alexander, S; Hanigan, MH; Min, J; Stegner, AL; Traynor, D; Zhang, L | 1 |
| Hu, CY; Lan, KH; Lu, Q; Tang, W; Wang, SF; Yin, GJ | 1 |
| Chang, W; Hu, B; Liang, Y; Wang, S; Zhang, Y | 1 |
6 other study(ies) available for fluorouracil and sphingosine
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Inhibition of skin sphingosine synthesis: enhanced percutaneous permeation of 5-fluorouracil.
Topics: Administration, Oral; Animals; Antimetabolites; Area Under Curve; beta-Alanine; Chemistry, Pharmaceutical; Enzyme Inhibitors; Fluorouracil; In Vitro Techniques; Rats; Skin; Skin Absorption; Solvents; Sphingosine | 2004 |
Overexpression of sphingosine-1-phosphate lyase or inhibition of sphingosine kinase in Dictyostelium discoideum results in a selective increase in sensitivity to platinum-based chemotherapy drugs.
Topics: Aldehyde-Lyases; Animals; Carboplatin; Cell Death; Cell Enlargement; Cell Nucleus; Ceramides; Cisplatin; Cloning, Molecular; Dictyostelium; Doxorubicin; Enzyme Inhibitors; Fluorouracil; Mutation; Parasitic Sensitivity Tests; Phosphotransferases (Alcohol Group Acceptor); Sphingolipids; Sphingosine | 2004 |
Sphingosine kinase regulates the sensitivity of Dictyostelium discoideum cells to the anticancer drug cisplatin.
Topics: Adenosine Triphosphate; Amino Acid Sequence; Animals; Antineoplastic Agents; Blotting, Western; Cisplatin; Dictyostelium; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Etoposide; Fluorouracil; Microscopy, Fluorescence; Models, Genetic; Molecular Sequence Data; Mutation; Phosphotransferases (Alcohol Group Acceptor); Recombination, Genetic; Sensitivity and Specificity; Sequence Homology, Amino Acid; Sphingosine; Time Factors | 2005 |
[Antitumor effect of sphingosine kinase 1 inhibitor in combination with chemotherapy on SGC7901 gastric cancer cells in vitro].
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Synergism; Enzyme Inhibitors; Fluorouracil; Humans; Mitomycin; Phosphotransferases (Alcohol Group Acceptor); Sphingosine; Stomach Neoplasms | 2012 |
Triple Negative Breast Cancer Depends on Sphingosine Kinase 1 (SphK1)/Sphingosine-1-Phosphate (S1P)/Sphingosine 1-Phosphate Receptor 3 (S1PR3)/Notch Signaling for Metastasis.
Topics: Animals; Cell Line, Tumor; Doxorubicin; Drug Synergism; Female; Fluorouracil; Heterografts; Humans; Lysophospholipids; MCF-7 Cells; Methanol; Mice; Mice, Inbred NOD; Mice, SCID; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Phosphotransferases (Alcohol Group Acceptor); Pyrrolidines; Receptor, ErbB-2; Receptors, Lysosphingolipid; Receptors, Notch; Signal Transduction; Sphingosine; Sphingosine-1-Phosphate Receptors; Sulfones; Triple Negative Breast Neoplasms; Up-Regulation | 2018 |